Applied Clinical Trials
December 22, 2015
View from Brussels
24
12
Despite orphan-drug R&D and approval being all the rage, issues such as patient access could leave these treatments out in the rain.
December 22, 2015
News
24
12
The discussions will center on ways clinical research can harness gene therapy and new and emerging diagnostic tools.
December 22, 2015
A Closing Thought
24
12
Exploring three pivotal technology areas that could reshape global studies over the next 10 years.
December 22, 2015
News
24
12
While approved in 2014, Europe's new regulation governing clinical studies is set to take effect in May-leaving interested parties only six more months to prepare for its arrival.
December 22, 2015
Feature Article
24
12
The country’s introduction of a new legal framework has it in sync with European law on clinical research.
December 22, 2015
Feature Article
24
12
Examining why newly registered trials have fallen in Central and Eastern Europe, relative to other regions.
December 22, 2015
Feature Article
24
12
Survey sheds light on the regional-specific risks of managing clinical trial sites in Eastern Europe.
December 22, 2015
Clinical Trial Insights
24
12
Study uncovers subtle distinctions in attitudes and perceptions among the two groups.
December 01, 2015
News
24
12
These three areas will be at center of drug development discussions in the year ahead.
December 01, 2015
Issue PDF
24
12
Regulatory: Assessing Study Drop in CEE Swiss Syncs Up Regulations Sites: Regional Risks in Eastern Europe Also in this issue: Orphan Drug Hurdles in Europe Patient Engagement: Illness-Level Impact Clinical Trial Technology in 2025
December 01, 2015
Issue PDF
24
12
Click the title above to open the Applied Clinical Trials December 2015/January 2016 issue in an interactive PDF format.